Skip to main content
profile image
Selected Works of Philip Mease, MD
Article
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
Annals of the Rheumatic Diseases (2018)
  • Philip Mease, University of Washington
  • Désirée van der Heijde, Leiden University
  • Robert Landewé, University of Amsterdam
  • Shephard Mpofu, Novartis
  • Proton Rahman, Memorial University of Newfoundland
  • Hasan Tahir, Barts Health NHS Trust
  • Atul Singhal
  • Elke Boettcher
  • Sandra Navarra, University of Santo Tomas Hospital
  • Karin Meiser, Novartis
  • Aimee Readie, Novartis
  • Luminita Pricop, Novartis
  • Ken Abrams, Novartis
Link
Disciplines
Publication Date
March 17, 2018
DOI
10.1136/annrheumdis-2017-212687
Citation Information
Philip Mease, Désirée van der Heijde, Robert Landewé, Shephard Mpofu, et al.. "Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study" Annals of the Rheumatic Diseases (2018)
Available at: http://works.bepress.com/philip-mease/4/